Characterization of two new variants of human catechol O-methyltransferase in vitro

Cancer Letters

Volumn 230, Issue 1, 2005, Pages 81-89

  Li, Yan ^a   Yang, Xiaofeng ^a   Van Breemen, Richard B ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

4 Hydroxyequilenin; COMT; Estrogen replacement therapy; Gene polymorphism

Indexed keywords

4 HYDROXYEQUILENIN; ALANINE; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; ESTROGEN DERIVATIVE; METHIONINE; RECOMBINANT DNA; SERINE; THREONINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; DNA METHYLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME POLYMORPHISM; ENZYME STABILITY; ENZYME SUBUNIT; ENZYMOLOGY; ESTROGEN THERAPY; GENETIC VARIABILITY; IN VITRO STUDY; METABOLISM; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOSTABILITY;

ALANINE; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; DNA METHYLATION; EQUILENIN; ESCHERICHIA COLI; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MUTAGENESIS, SITE-DIRECTED; PLASMIDS; POLYMORPHISM, GENETIC; SERINE; TEMPERATURE;

EID: 27144522028     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.022     Document Type: Article

References (35)

1. J. Axelrod, and R. Tomchick Enzymatic O-methylation of epinephrine and other catechols J. Biol. Chem. 233 1958 702 705
2. E.R. Barnea, and S. Avigdor Coordinated induction of estrogen hydroxylase and catechol-O-methyl transferase by xenobiotics in first trimester human placental explants J. Steroid Biochem. 35 1990 327 331
3. J. Axelrod Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines Pharmacol. Rev. 18 1966 95 113
4. P. Ball, and R. Knuppen Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance Acta Endocrinol. Suppl. (Copenhagen) 232 1980 1 127
5. M. Salminen, K. Lundstrom, C. Tilgmann, R. Savolainen, N. Kalkkinen, and I. Ulmanen Molecular cloning and characterization of rat liver catechol-O-methyltransferase Gene 93 1990 241 247
6. K. Lundstrom, M. Salminen, A. Jalanko, R. Savolainen, and I. Ulmanen Cloning and characterization of human placental catechol-O-methyltransferase cDNA DNA Cell Biol. 10 1991 181 189
7. K. Lundstrom, J. Tenhunen, C. Tilgmann, T. Karhunen, P. Panula, and I. Ulmanen Cloning, expression and structure of catechol-O-methyltransferase Biochim. Biophys. Acta 1251 1995 1 10
8. C.K. Cohn, D.L. Dunner, and J. Axelrod Reduced catechol-O- methyltransferase activity in red blood cells of women with primary affective disorder Science 170 1970 1323 1324
9. R.M. Weinshilboum, and F.A. Raymond Inheritance of low erythrocyte catechol-o-methyltransferase activity in man Am. J. Hum. Genet. 29 1977 125 135
10. T. Lotta, J. Vidgren, C. Tilgmann, I. Ulmanen, K. Melen, I. Julkunen, and J. Taskinen Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme Biochemistry 34 1995 4202 4210
11. H.M. Lachman, D.F. Papolos, T. Saito, Y.M. Yu, C.L. Szumlanski, and R.M. Weinshilboum Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 1996 243 250
12. M.T. Goodman, K. McDuffie, L.N. Kolonel, K. Terada, T.A. Donlon, and L.R. Wilkens Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism Cancer Epidemiol. Biomarkers Prev. 10 2001 209 216
13. J.A. Lavigne, K.J. Helzlsouer, H.Y. Huang, P.T. Strickland, D.A. Bell, and O. Selmin An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer Cancer Res. 57 1997 5493 5497
14. M. Karayiorgou, M. Altemus, B.L. Galke, D. Goldman, D.L. Murphy, J. Ott, and J.A. Gogos Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder Proc. Natl Acad. Sci. USA 94 1997 4572 4575
15. G. Kirov, K.C. Murphy, M.J. Arranz, I. Jones, F. McCandles, and H. Kunugi Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder Mol. Psychiatry 3 1998 342 345
16. A.J. Shield, B.A. Thomae, B.W. Eckloff, E.D. Wieben, and R.M. Weinshilboum Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes Mol. Psychiatry 9 2004 151 160
17. S. Saito, A. Iida, A. Sekine, Y. Miura, T. Sakamoto, and C. Ogawa Identification of 197 genetic variations in six human methyltranferase genes in the Japanese population J. Hum. Genet. 46 2001 529 537
18. M. Cargill, D. Altshuler, J. Ireland, P. Sklar, K. Ardlie, and N. Patil Characterization of single-nucleotide polymorphisms in coding regions of human genes Nat. Genet. 22 1999 231 238
19. Y. Li, J. Yao, M. Chang, D. Nikolic, L. Yu, and J.D. Yager Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase Chem. Res. Toxicol. 17 2004 512 520
20. J.E. Goodman, L.T. Jensen, P. He, and J.D. Yager Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation Pharmacogenetics 12 2002 517 528
21. NIH Guidelines for the Laboratory Use of Chemical Carcinogens, US Government Printing Office, Washington, DC, 1981.
22. H.J. Teuber Reactions with nitrosodisulfonate (III). Equilenin-quinone Chem. Ber. 86 1953 1495 1499
23. X. Han, and J.G. Liehr Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones Carcinogenesis 16 1995 2571 2574
24. J.L. Bolton, E. Pisha, L. Shen, E.S. Krol, S.L. Iverson, and Z. Huang The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkylcatechol-induced toxicity in human melanoma cells Chem. Biol. Interact. 106 1997 133 148
25. D.C. Spink, F. Zhang, M.M. Hussain, B.H. Katz, X. Liu, D.R. Hilker, and J.L. Bolton Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells Chem. Res. Toxicol. 14 2001 572 581
26. P.N. Rao, and C.W. Somawardhana Synthesis of 2-methoxy and 4-methoxy equine estrogens Steroids 49 1987 419 432
27. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
28. J. Yao, Y. Li, M. Chang, H. Wu, X. Yang, and J.E. Goodman Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase Chem. Res. Toxicol. 16 2003 668 675
29. R. Kitz, and I.B. Wilson Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase J. Biol. Chem. 237 1962 3245 3249
30. S. Dawling, N. Roodi, R.L. Mernaugh, X. Wang, and F.F. Parl Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms Cancer Res. 61 2001 6716 6722
31. P.D. Scanlon, F.A. Raymond, and R.M. Weinshilboum Catechol-O- methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity Science 203 1979 63 65
32. K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.M. Kosma, and S. Benhamou Polymorphic catechol-O-methyltransferase gene and breast cancer risk Cancer Epidemiol. Biomarkers Prev. 10 2001 635 640
33. P.A. Thompson, P.G. Shields, J.L. Freudenheim, A. Stone, J.E. Vena, and J.R. Marshall Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk Cancer Res. 58 1998 2107 2110
34. R.D. Strous, N. Bark, S.S. Parsia, J. Volavka, and H.M. Lachman Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior Psychiatry Res. 69 1997 71 77
35. LL) is associated with low levels of COMT protein in human hepatocytes Cancer Lett. 214 2004 189 195